Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18482
Country/Region: South Africa
Year: 2018
Main Partner: TB/HIV Care Association
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $32,783,141 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $3,076,598
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $4,227,940
Care: Pediatric Care and Support (PDCS) $1,595,867
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $418,310
Testing: HIV Testing and Counseling (HVCT) $3,914,555
Sexual Prevention: Other Sexual Prevention (HVOP) $4,090,644
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $451,994
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $13,140,172
Treatment: Pediatric Treatment (PDTX) $1,867,061
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST 25-29, Female, Negative 2019 1,101
HTS_TST 25-29, Female, Negative 2019 549
HTS_TST 25-29, Female, Negative 2019 949
HTS_TST 25-29, Female, Negative 2019 8,508
HTS_TST 25-29, Female, Negative 2019 4,684
HTS_TST 25-29, Female, Negative 2019 35,890
HTS_TST 25-29, Female, Negative 2019 3,665
HTS_TST 25-29, Female, Negative 2019 9,916
HTS_TST 25-29, Female, Negative 2019 179
HTS_TST 25-29, Female, Negative 2019 52
HTS_TST 25-29, Female, Negative 2019 103
HTS_TST 25-29, Female, Negative 2019 4,025
HTS_TST 25-29, Male, Negative 2019 355
HTS_TST 25-29, Male, Negative 2019 598
HTS_TST 25-29, Male, Negative 2019 5,412
HTS_TST 25-29, Male, Negative 2019 5,102
HTS_TST 25-29, Male, Negative 2019 22,614
HTS_TST 25-29, Male, Negative 2019 96
HTS_TST 25-29, Male, Negative 2019 11
HTS_TST 25-29, Male, Negative 2019 66
HTS_TST 25-29, Male, Negative 2019 2,534
HTS_TST 30-34, Female, Negative 2019 5,834
HTS_TST 30-34, Female, Negative 2019 665
HTS_TST 30-34, Female, Negative 2019 801
HTS_TST 30-34, Female, Negative 2019 1,382
HTS_TST 30-34, Female, Negative 2019 11,391
HTS_TST 30-34, Female, Negative 2019 5,583
HTS_TST 30-34, Female, Negative 2019 52,139
HTS_TST 30-34, Female, Negative 2019 2,747
HTS_TST 30-34, Female, Negative 2019 5,971
HTS_TST 30-34, Female, Negative 2019 319
HTS_TST 30-34, Female, Negative 2019 86
HTS_TST 30-34, Female, Negative 2019 147
HTS_TST 30-34, Male, Negative 2019 4,022
HTS_TST 30-34, Male, Negative 2019 568
HTS_TST 30-34, Male, Negative 2019 955
HTS_TST 30-34, Male, Negative 2019 8,286
HTS_TST 30-34, Male, Negative 2019 6,272
HTS_TST 30-34, Male, Negative 2019 35,946
HTS_TST 30-34, Male, Negative 2019 201
HTS_TST 30-34, Male, Negative 2019 51
HTS_TST 30-34, Male, Negative 2019 102
HTS_TST 35-39, Female, Negative 2019 4,845
HTS_TST 35-39, Female, Negative 2019 397
HTS_TST 35-39, Female, Negative 2019 660
HTS_TST 35-39, Female, Negative 2019 1,146
HTS_TST 35-39, Female, Negative 2019 14,600
HTS_TST 35-39, Female, Negative 2019 5,998
HTS_TST 35-39, Female, Negative 2019 43,293
HTS_TST 35-39, Female, Negative 2019 1,831
HTS_TST 35-39, Female, Negative 2019 3,582
HTS_TST 35-39, Female, Negative 2019 249
HTS_TST 35-39, Female, Negative 2019 67
HTS_TST 35-39, Female, Negative 2019 122
HTS_TST 35-39, Male, Negative 2019 4,253
HTS_TST 35-39, Male, Negative 2019 594
HTS_TST 35-39, Male, Negative 2019 1,002
HTS_TST 35-39, Male, Negative 2019 13,199
HTS_TST 35-39, Male, Negative 2019 7,383
HTS_TST 35-39, Male, Negative 2019 37,972
HTS_TST 35-39, Male, Negative 2019 214
HTS_TST 35-39, Male, Negative 2019 55
HTS_TST 35-39, Male, Negative 2019 107
HTS_TST 40-49, Female, Negative 2019 7,792
HTS_TST 40-49, Female, Negative 2019 148
HTS_TST 40-49, Female, Negative 2019 14
HTS_TST 40-49, Female, Negative 2019 1,070
HTS_TST 40-49, Female, Negative 2019 1,848
HTS_TST 40-49, Female, Negative 2019 16,660
HTS_TST 40-49, Female, Negative 2019 5,998
HTS_TST 40-49, Female, Negative 2019 69,620
HTS_TST 40-49, Female, Negative 2019 1,348
HTS_TST 40-49, Female, Negative 2019 450
HTS_TST 40-49, Female, Negative 2019 115
HTS_TST 40-49, Female, Negative 2019 195
HTS_TST 40-49, Male, Negative 2019 12,776
HTS_TST 40-49, Male, Negative 2019 83
HTS_TST 40-49, Male, Negative 2019 1,792
HTS_TST 40-49, Male, Negative 2019 3,015
HTS_TST 40-49, Male, Negative 2019 18,103
HTS_TST 40-49, Male, Negative 2019 7,767
HTS_TST 40-49, Male, Negative 2019 114,098
HTS_TST 40-49, Male, Negative 2019 749
HTS_TST 40-49, Male, Negative 2019 198
HTS_TST 40-49, Male, Negative 2019 321
HTS_TST By Key Population: FSW, Negative 2019 18,323
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 91,122
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 1,076,361
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 2,352
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 606
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 604
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 1,980
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 1,084
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 3,171
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 2,144
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 4,391
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 7,380
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 2,107
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 1,868
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 6,731
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 4,883
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 15,949
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 3,263
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 2,250
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 2,978
HTS_TST Service Delivery Point (Community) Other: 1-9, Negative 2019 44
HTS_TST Service Delivery Point (Community) Other: 1-9, Negative 2019 638
HTS_TST Service Delivery Point (Community) Other: 10-14, Female, Negative 2019 100
HTS_TST Service Delivery Point (Community) Other: 10-14, Male, Negative 2019 84
HTS_TST Service Delivery Point (Community) Other: 10-14, Male, Negative 2019 1,554
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 6,413
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 3,665
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 153
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 2,888
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 315
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 9,029
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 1,001
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 38
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 1,054
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 113
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 230
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 225
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 423
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 27
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 873
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 80
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 1,368
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 151
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 285
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 23
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 129
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 207
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 26
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 56
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 527
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 12
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 126
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 12
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 127
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 75
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 697
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 197
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 1,980
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 237
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 2,219
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 70
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 693
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 28
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 276
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 42
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 388
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 2,212
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 19,937
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 523
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 4,688
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 1,717
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 523
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 4,688
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 2,967
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 26,504
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 8,164
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 73,329
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 9,441
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 84,218
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 2,869
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 25,820
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 1,171
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 10,474
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 1,644
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 14,688
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 3,652
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 32,819
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 260
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 18
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 18
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 132
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 22
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 301
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 56
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 546
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 68
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 18
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 48
HTS_TST_POS 25-29, Female, Positive 2019 188
HTS_TST_POS 25-29, Female, Positive 2019 107
HTS_TST_POS 25-29, Female, Positive 2019 82
HTS_TST_POS 25-29, Female, Positive 2019 399
HTS_TST_POS 25-29, Female, Positive 2019 828
HTS_TST_POS 25-29, Female, Positive 2019 1,650
HTS_TST_POS 25-29, Female, Positive 2019 647
HTS_TST_POS 25-29, Female, Positive 2019 1,655
HTS_TST_POS 25-29, Female, Positive 2019 178
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 184
HTS_TST_POS 25-29, Male, Positive 2019 52
HTS_TST_POS 25-29, Male, Positive 2019 58
HTS_TST_POS 25-29, Male, Positive 2019 256
HTS_TST_POS 25-29, Male, Positive 2019 898
HTS_TST_POS 25-29, Male, Positive 2019 1,074
HTS_TST_POS 25-29, Male, Positive 2019 108
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 5
HTS_TST_POS 25-29, Male, Positive 2019 120
HTS_TST_POS 30-34, Female, Positive 2019 266
HTS_TST_POS 30-34, Female, Positive 2019 152
HTS_TST_POS 30-34, Female, Positive 2019 169
HTS_TST_POS 30-34, Female, Positive 2019 120
HTS_TST_POS 30-34, Female, Positive 2019 548
HTS_TST_POS 30-34, Female, Positive 2019 985
HTS_TST_POS 30-34, Female, Positive 2019 2,400
HTS_TST_POS 30-34, Female, Positive 2019 484
HTS_TST_POS 30-34, Female, Positive 2019 1,340
HTS_TST_POS 30-34, Female, Positive 2019 285
HTS_TST_POS 30-34, Female, Positive 2019 1
HTS_TST_POS 30-34, Female, Positive 2019 13
HTS_TST_POS 30-34, Male, Positive 2019 196
HTS_TST_POS 30-34, Male, Positive 2019 104
HTS_TST_POS 30-34, Male, Positive 2019 80
HTS_TST_POS 30-34, Male, Positive 2019 395
HTS_TST_POS 30-34, Male, Positive 2019 1,106
HTS_TST_POS 30-34, Male, Positive 2019 1,723
HTS_TST_POS 30-34, Male, Positive 2019 208
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 9
HTS_TST_POS 35-39, Female, Positive 2019 226
HTS_TST_POS 35-39, Female, Positive 2019 75
HTS_TST_POS 35-39, Female, Positive 2019 126
HTS_TST_POS 35-39, Female, Positive 2019 106
HTS_TST_POS 35-39, Female, Positive 2019 571
HTS_TST_POS 35-39, Female, Positive 2019 1,059
HTS_TST_POS 35-39, Female, Positive 2019 1,991
HTS_TST_POS 35-39, Female, Positive 2019 324
HTS_TST_POS 35-39, Female, Positive 2019 851
HTS_TST_POS 35-39, Female, Positive 2019 240
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 12
HTS_TST_POS 35-39, Male, Positive 2019 212
HTS_TST_POS 35-39, Male, Positive 2019 110
HTS_TST_POS 35-39, Male, Positive 2019 83
HTS_TST_POS 35-39, Male, Positive 2019 537
HTS_TST_POS 35-39, Male, Positive 2019 1,306
HTS_TST_POS 35-39, Male, Positive 2019 1,815
HTS_TST_POS 35-39, Male, Positive 2019 229
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 9
HTS_TST_POS 40-49, Female, Positive 2019 359
HTS_TST_POS 40-49, Female, Positive 2019 11
HTS_TST_POS 40-49, Female, Positive 2019 252
HTS_TST_POS 40-49, Female, Positive 2019 160
HTS_TST_POS 40-49, Female, Positive 2019 766
HTS_TST_POS 40-49, Female, Positive 2019 1,059
HTS_TST_POS 40-49, Female, Positive 2019 3,204
HTS_TST_POS 40-49, Female, Positive 2019 180
HTS_TST_POS 40-49, Female, Positive 2019 368
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 19
HTS_TST_POS 40-49, Male, Positive 2019 622
HTS_TST_POS 40-49, Male, Positive 2019 70
HTS_TST_POS 40-49, Male, Positive 2019 447
HTS_TST_POS 40-49, Male, Positive 2019 262
HTS_TST_POS 40-49, Male, Positive 2019 1,035
HTS_TST_POS 40-49, Male, Positive 2019 1,373
HTS_TST_POS 40-49, Male, Positive 2019 5,480
HTS_TST_POS 40-49, Male, Positive 2019 649
HTS_TST_POS 40-49, Male, Positive 2019 29
HTS_TST_POS 40-49, Male, Positive 2019 26
HTS_TST_POS By Key Population: FSW, Positive 2019 3,233
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 55
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 30
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 25
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 348
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 191
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 557
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 378
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 775
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 1,302
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 71
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2019 53
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 290
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 536
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 835
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 231
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 124
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 164
HTS_TST_POS Service Delivery Point (Community) Other: 1-9, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Female, Positive 2019 88
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Male, Positive 2019 60
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 1,133
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 647
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 185
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 967
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 108
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 1,974
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 222
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 53
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 124
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 191
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 336
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 49
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 58
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 27
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 62
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 176
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 195
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 67
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 227
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 2,003
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 118
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 1,098
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 98
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 907
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 148
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 1,321
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 267
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 2,479
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 471
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 4,182
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 82
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 874
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 36
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 489
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 70
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 703
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 70
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 669
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 85
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 149
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 117
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 53
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 518
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 55
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 23,748
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 23,748
PMTCT_ART Already on ART at beginning of current pregnancy 2019 10,176
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,130
PMTCT_ART New on ART 2019 7,900
PMTCT_ART New on ART 2019 883
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 18,076
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 2,013
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 51,362
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 5,707
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 16,648
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 1,852
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 887
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 94
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 17,535
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 1,946
PMTCT_EID Sum of Infant Age disaggregates 2019 17,535
PMTCT_EID Sum of Infant Age disaggregates 2019 1,946
PMTCT_STAT 25-29, Female 2019 14,155
PMTCT_STAT 25-29, Female 2019 1,573
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 2,629
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 289
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 9,917
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 1,101
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 1,654
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 188
PMTCT_STAT 30-34, Female 2019 9,497
PMTCT_STAT 30-34, Female 2019 1,050
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 2,149
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 234
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 5,971
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 665
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 1,371
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 152
PMTCT_STAT 35-39, Female 2019 5,695
PMTCT_STAT 35-39, Female 2019 632
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 1,264
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 138
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 3,588
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 397
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 818
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 75
PMTCT_STAT 40-49, Female 2019 1,926
PMTCT_STAT 40-49, Female 2019 216
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 353
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 35
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 1,340
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 148
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 197
PMTCT_STAT By Age (Numerator): : 15-19 2019 592
PMTCT_STAT By Age (Numerator): 10-14 2019 564
PMTCT_STAT By Age (Numerator): 10-14 2019 68
PMTCT_STAT By Age (Numerator): 15-19 2019 5,269
PMTCT_STAT By Age (Numerator): 20-24 2019 14,117
PMTCT_STAT By Age (Numerator): 20-24 2019 1,565
PMTCT_STAT By Age (Numerator): 50+ 2019 117
PMTCT_STAT By known positives: 10-14 2019 7
PMTCT_STAT By known positives: 15-19 2019 160
PMTCT_STAT By known positives: 20-24 2019 352
PMTCT_STAT By new negatives: 15-19 2019 315
PMTCT_STAT By new negatives: 20-24 2019 1,001
PMTCT_STAT By new positives: 15-19 2019 108
PMTCT_STAT By new positives: 20-24 2019 222
PMTCT_STAT By Number of known positives: 10-14 2019 257
PMTCT_STAT By Number of known positives: 15-19 2019 1,422
PMTCT_STAT By Number of known positives: 20-24 2019 3,103
PMTCT_STAT By Number of known positives: 50+ 2019 32
PMTCT_STAT By Number of new negative: 10-14 2019 153
PMTCT_STAT By Number of new negative: 15-19 2019 2,884
PMTCT_STAT By Number of new negative: 20-24 2019 9,028
PMTCT_STAT By Number of new negative: 50+ 2019 38
PMTCT_STAT By Number of new positives: 10-14 2019 185
PMTCT_STAT By Number of new positives: 15-19 2019 971
PMTCT_STAT By Number of new positives: 20-24 2019 1,963
PMTCT_STAT By Number of new positives: 50+ 2019 10
PMTCT_STAT Number of new ANC and L&D clients 2019 51,857
PMTCT_STAT Number of new ANC and L&D clients 2019 5,785
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 51,362
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 5,707
PMTCT_STAT_den 25-29, Female 2019 13,766
PMTCT_STAT_den 25-29, Female 2019 1,555
PMTCT_STAT_den 30-34, Female 2019 9,377
PMTCT_STAT_den 30-34, Female 2019 1,041
PMTCT_STAT_den 35-39, Female 2019 5,610
PMTCT_STAT_den 35-39, Female 2019 625
PMTCT_STAT_den 40-49, Female 2019 1,875
PMTCT_STAT_den 40-49, Female 2019 207
PMTCT_STAT_den By Age (Denominator): <15-19 2019 6,198
PMTCT_STAT_den By Age (Denominator): 10-14 2019 857
PMTCT_STAT_den By Age (Denominator): 10-14 2019 93
PMTCT_STAT_den By Age (Denominator): 15-19 2019 692
PMTCT_STAT_den By Age (Denominator): 20-24 2019 13,935
PMTCT_STAT_den By Age (Denominator): 20-24 2019 1,550
PMTCT_STAT_den By Age (Denominator): 50+ 2019 239
PMTCT_STAT_den By Age (Denominator): 50+ 2019 22
PP_PREV 25-29, Female 2019 6,552
PP_PREV 25-29, Male 2019 7,166
PP_PREV 30-34, Female 2019 3,605
PP_PREV 30-34, Male 2019 2,110
PP_PREV 35-39, Female 2019 1,382
PP_PREV 35-39, Male 2019 1,334
PP_PREV Age/sex: 10-14 Female 2019 13,557
PP_PREV Age/sex: 10-14 Male 2019 5,273
PP_PREV Age/sex: 15-19 Female 2019 30,515
PP_PREV Age/sex: 15-19 Male 2019 14,693
PP_PREV Age/sex: 20-24 Female 2019 11,667
PP_PREV Age/sex: 20-24 Male 2019 7,382
PP_PREV Age/sex: 50+ Female 2019 124
PP_PREV Age/sex: 50+ Male 2019 22
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 105,461
PP_PREV Sum of Age/Sex disaggregates 2019 83,233
PrEP_NEW 25-29, Female 2019 1,134
PrEP_NEW 30-34, Female 2019 1,134
PrEP_NEW 35-39, Female 2019 864
PrEP_NEW 40-49, Female 2019 597
PrEP_NEW Female 15-19 2019 3,263
PrEP_NEW Female 20-24 2019 4,720
PrEP_NEW Female 50+ 2019 326
PrEP_NEW FSW 2019 5,589
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 12,038
PrEP_NEW Other Key Populations 2019 6,449
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 246
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 2,317
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 226
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 88
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,543
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 195
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 4,194
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 421
TB_PREV By Age/Sex (Numerator): <15, Female 2019 1,303
TB_PREV By Age/Sex (Numerator): <15, Female 2019 142
TB_PREV By Age/Sex (Numerator): <15, Male 2019 1,303
TB_PREV By Age/Sex (Numerator): <15, Male 2019 142
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 39,644
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 4,414
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 16,576
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 1,841
TB_PREV IPT, Life-long ART, Already, Positive 2019 5,876
TB_PREV IPT, Life-long ART, Already, Positive 2019 656
TB_PREV IPT, Life-long ART, New, Positive 2019 52,920
TB_PREV IPT, Life-long ART, New, Positive 2019 5,883
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 58,812
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 6,531
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 84,026
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 9,337
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 1,857
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 211
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 1,857
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 211
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 56,635
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 6,308
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 23,671
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 2,637
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 8,406
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 931
TB_PREV_den IPT, Life-long ART, New, Positive 2019 75,615
TB_PREV_den IPT, Life-long ART, New, Positive 2019 8,404
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 335
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 4,934
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 500
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 123
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 3,292
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 325
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 8,671
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 863
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 8,839
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 879
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 340
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 4,959
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 502
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 126
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3,297
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 329
TX_CURR 25-29, Female, Positive 2019 22,440
TX_CURR 25-29, Female, Positive 2019 2,259
TX_CURR 25-29, Male, Positive 2019 7,681
TX_CURR 25-29, Male, Positive 2019 765
TX_CURR 30-34, Female, Positive 2019 32,645
TX_CURR 30-34, Female, Positive 2019 3,240
TX_CURR 30-34, Male, Positive 2019 12,220
TX_CURR 30-34, Male, Positive 2019 1,215
TX_CURR 35-39, Female, Positive 2019 27,098
TX_CURR 35-39, Female, Positive 2019 2,694
TX_CURR 35-39, Male, Positive 2019 12,902
TX_CURR 35-39, Male, Positive 2019 1,282
TX_CURR 40-49, Female, Positive 2019 43,585
TX_CURR 40-49, Female, Positive 2019 4,329
TX_CURR 40-49, Male, Positive 2019 38,771
TX_CURR 40-49, Male, Positive 2019 3,848
TX_CURR Age/Sex: <1 2019 791
TX_CURR Age/Sex: <1 2019 76
TX_CURR Age/Sex: <1-9 2019 5,124
TX_CURR Age/Sex: 1-9 2019 568
TX_CURR Age/Sex: 10-14 Female 2019 5,259
TX_CURR Age/Sex: 10-14 Female 2019 587
TX_CURR Age/Sex: 10-14 Male 2019 3,521
TX_CURR Age/Sex: 10-14 Male 2019 392
TX_CURR Age/Sex: 15-19 Female 2019 7,367
TX_CURR Age/Sex: 15-19 Female 2019 725
TX_CURR Age/Sex: 15-19 Male 2019 5,673
TX_CURR Age/Sex: 15-19 Male 2019 562
TX_CURR Age/Sex: 20-24 Female 2019 23,387
TX_CURR Age/Sex: 20-24 Female 2019 2,323
TX_CURR Age/Sex: 20-24 Male 2019 2,006
TX_CURR Age/Sex: 20-24 Male 2019 194
TX_CURR Age/Sex: 50+ Female 2019 6,554
TX_CURR Age/Sex: 50+ Female 2019 649
TX_CURR Age/Sex: 50+ Male 2019 4,988
TX_CURR Age/Sex: 50+ Male 2019 493
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 262,012
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 26,201
TX_CURR Sum of age/sex disaggregates 2019 13,040
TX_CURR Sum of Age/Sex disaggregations 2019 1,287
TX_NEW 25-29, Female, Positive 2019 3,052
TX_NEW 25-29, Female, Positive 2019 271
TX_NEW 25-29, Male, Positive 2019 1,784
TX_NEW 25-29, Male, Positive 2019 178
TX_NEW 30-34, Female, Positive 2019 4,298
TX_NEW 30-34, Female, Positive 2019 394
TX_NEW 30-34, Male, Positive 2019 2,848
TX_NEW 30-34, Male, Positive 2019 282
TX_NEW 35-39, Female, Positive 2019 3,560
TX_NEW 35-39, Female, Positive 2019 328
TX_NEW 35-39, Male, Positive 2019 3,005
TX_NEW 35-39, Male, Positive 2019 296
TX_NEW 40-49, Female, Positive 2019 5,503
TX_NEW 40-49, Female, Positive 2019 534
TX_NEW 40-49, Male, Positive 2019 9,064
TX_NEW 40-49, Male, Positive 2019 897
TX_NEW By Age/Sex: <1 2019 152
TX_NEW By Age/Sex: <1 2019 2
TX_NEW By Age/Sex: 1-9 2019 2,311
TX_NEW By Age/Sex: 1-9 2019 254
TX_NEW By Age/Sex: 10-14 Female 2019 1,273
TX_NEW By Age/Sex: 10-14 Female 2019 147
TX_NEW By Age/Sex: 10-14 Male 2019 1,041
TX_NEW By Age/Sex: 10-14 Male 2019 107
TX_NEW By Age/Sex: 15-19 Female 2019 2,306
TX_NEW By Age/Sex: 15-19 Female 2019 220
TX_NEW By Age/Sex: 15-19 Male 2019 4,517
TX_NEW By Age/Sex: 15-19 Male 2019 442
TX_NEW By Age/Sex: 20-24 Female 2019 7,161
TX_NEW By Age/Sex: 20-24 Female 2019 686
TX_NEW By Age/Sex: 20-24 Male 2019 1,604
TX_NEW By Age/Sex: 20-24 Male 2019 160
TX_NEW By Age/Sex: 50+ Female 2019 878
TX_NEW By Age/Sex: 50+ Female 2019 77
TX_NEW By Age/Sex: 50+ Male 2019 1,186
TX_NEW By Age/Sex: 50+ Male 2019 107
TX_NEW FSW 2019 1,273
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 55,580
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 5,412
TX_NEW Pregnancy status 2019 195
TX_NEW Sum of Age/Sex disaggregates 2019 19,966
TX_NEW Sum of Age/Sex disaggregates 2019 1,946
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 27,778
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months. 2019 250,003
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 4,996
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 545
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 867
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 88
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 4,985
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 545
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 867
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 88
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 100,205
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 11,179
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 17,686
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 1,962
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 102,338
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 11,373
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 18,059
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 1,998
TX_PVLS_den Denominator: Indication: Routine 2019 212,512
TX_PVLS_den Denominator: Indication: Routine 2019 23,607
TX_PVLS_den Denominator: Indication: Targeted 2019 37,500
TX_PVLS_den Denominator: Indication: Targeted 2019 4,166
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,424
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 371
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,415
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 371
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 61,799
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 6,868
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 25,944
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,888
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 94,519
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 10,504
TX_RET Numerator by Status: Pregnant 2019 3,637
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 105,016
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 11,666
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,740
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 414
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,721
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 414
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 68,667
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 7,629
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 28,896
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,196
TX_RET_den Denominator by Status: Pregnant 2019 4,541
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 262,012
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 26,201
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 5,943
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 594
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 4,116
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 406
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 12,464
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 12,730
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 124,657
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 127,296
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 161,396
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 16,143
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 31,452
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 3,142
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 16,766
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 1,676
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 20,962
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 209,601
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 56,258
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 5,620
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 3,958
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 390
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 188,410
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 18,840
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 13,402
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 1,341
Cross Cutting Budget Categories and Known Amounts Total: $26,091,762
Key Populations: MSM and TG $750,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Monitoring and evaluation of MSM/TG programs
Gender: Gender Based Violence (GBV) $250,000
Post GBV Care
GBV Prevention
Adolescent Girls and Young Women (AGYW) $3,391,762
Human Resources for Health $20,700,000
Motor Vehicles: Leased $1,000,000